Clinical trialNCT00323570WithdrawnPhase 3Interventional

Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma

SponsorNovo Nordisk A/SEnrollment0Acquired Bleeding DisorderTrauma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This trial is conducted in the United States of America (USA). The purpose of this study is to evaluate the treatment of Recombinant Faction VIIa in Patients with Severe Bleeding Due to Trauma Please note that this trial and trial F7TRAUMA-1711 (NCT00184548) have been merged.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Bartholomew Tortella, MD
Novo Nordisk A/S
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Novo Nordisk Clinical Trial Call Center
Phoenix, Arizona, United States
Novo Nordisk Clinical Trial Call Center
Los Angeles, California, United States
Novo Nordisk Clinical Trial Call Center
Sacramento, California, United States
Novo Nordisk Clinical Trial Call Center
Colorado Springs, Colorado, United States
Novo Nordisk Clinical Trial Call Center
Washington D.C., District of Columbia, United States
Novo Nordisk Clinical Trial Call Center
Gainesville, Florida, United States
Novo Nordisk Clinical Trial Call Center
Jacksonville, Florida, United States
Novo Nordisk Clinical Trial Call Center
Miami, Florida, United States
Novo Nordisk Clinical Trial Call Center
Chicago, Illinois, United States
Novo Nordisk Clinical Trial Call Center
Maywood, Illinois, United States
Novo Nordisk Clinical Trial Call Center
Indianapolis, Indiana, United States
Novo Nordisk Clinical Trial Call Center
Louisville, Kentucky, United States
Novo Nordisk Clinical Trial Call Center
Portland, Maine, United States
Novo Nordisk Clinical Trial Call Center
Baltimore, Maryland, United States
Novo Nordisk Clinical Trial Call Center
Boston, Massachusetts, United States
Novo Nordisk Clinical Trial Call Center
Detroit, Michigan, United States
Novo Nordisk Clinical Trial Call Center
Springfield, Missouri, United States
Novo Nordisk Clinical Trial Call Center
St Louis, Missouri, United States
Novo Nordisk Clinical Trial Call Center
Las Vegas, Nevada, United States
Novo Nordisk Clinical Trial Call Center
Camden, New Jersey, United States
Novo Nordisk Clinical Trial Call Center
Brooklyn, New York, United States
Novo Nordisk Clinical Trial Call Center
The Bronx, New York, United States
Novo Nordisk Clinical Trial Call Center
Greenville, North Carolina, United States
Novo Nordisk Clinical Trial Call Center
Winston-Salem, North Carolina, United States
Novo Nordisk Clinical Trial Call Center
Akron, Ohio, United States
Novo Nordisk Clinical Trial Call Center
Cleveland, Ohio, United States
Novo Nordisk Clinical Trial Call Center
Columbus, Ohio, United States
Novo Nordisk Clinical Trial Call Center
Oklahoma City, Oklahoma, United States
Novo Nordisk Clinical Trial Call Center
Portland, Oregon, United States
Novo Nordisk Clinical Trial Call Center
Allentown, Pennsylvania, United States
Novo Nordisk Clinical Trial Call Center
Philadelphia, Pennsylvania, United States
Novo Nordisk Clinical Trial Call Center
Philadelphia, Pennsylvania, United States
Novo Nordisk Clinical Trial Call Center
Philadelphia, Pennsylvania, United States
Novo Nordisk Clinical Trial Call Center
Pittsburgh, Pennsylvania, United States
Novo Nordisk Clinical Trial Call Center
Providence, Rhode Island, United States
Novo Nordisk Clinical Trial Call Center
Memphis, Tennessee, United States
Novo Nordisk Clinical Trial Call Center
Nashville, Tennessee, United States
Novo Nordisk Clinical Trial Call Center
Fort Sam Houston, Texas, United States
Novo Nordisk Clinical Trial Call Center
Lackland Air Force Base, Texas, United States
Novo Nordisk Clinical Trial Call Center
San Antonio, Texas, United States

2 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Factor VIIa

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 2006
Primary completion: 30 Jun 2007
Completion: 30 Jun 2007
Last update posted: 27 Jun 2012
Registered enrollment: 0
Registry id: NCT00323570

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.